The Impact of Biologics and Tofacitinib on Cardiovascular Risk Factors and Outcomes in Patients with Rheumatic Disease: A Systematic Literature Review
Crossref DOI link: https://doi.org/10.1007/s40264-017-0628-9
Published Online: 2018-01-09
Published Print: 2018-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nurmohamed, Michael
Choy, Ernest
Lula, Sadiq
Kola, Blerina
DeMasi, Ryan
Accossato, Paola
Funding for this research was provided by:
Pfizer
License valid from 2018-01-09